
The topical calcineurin antagonist tacrolimus plays an important role in the treatment of different forms of eczema because of its favorable risk profile. In addition, different off-label indications have been clinically tested where tacrolimus ointment has achieved clinical improvement. This article discusses off-label treatment of vitiligo, seborrheic dermatitis, steroid rosacea, perioral dermatitis, rosacea and lichen sclerosus.
Evidence-Based Medicine, Drug-Related Side Effects and Adverse Reactions, Administration, Topical, Off-Label Use, Skin Diseases, Tacrolimus, Treatment Outcome, Chronic Disease, Humans, Dermatologic Agents, Immunosuppressive Agents
Evidence-Based Medicine, Drug-Related Side Effects and Adverse Reactions, Administration, Topical, Off-Label Use, Skin Diseases, Tacrolimus, Treatment Outcome, Chronic Disease, Humans, Dermatologic Agents, Immunosuppressive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 11 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
